Blood vessel formation, or angiogenesis, is a fundamental biological process that supports tissue growth, repair, and nutrient supply. It is also a key feature in many medical conditions, including cancer, cardiovascular diseases, chronic inflammation, and wound healing. To understand these processes, researchers rely on molecular markers that specifically highlight endothelial cells—the cells that line the interior surface of blood vessels. Among these markers, CD31 has emerged as one of the most widely used and reliable indicators of vascular structures in both healthy and diseased tissues.
CD31, also known as PECAM 1 (Platelet Endothelial Cell Adhesion Molecule-1), is a transmembrane protein expressed abundantly on endothelial cells. Because of its consistent and strong expression, it serves as a highly specific marker for identifying blood vessels across species. The anti-CD31 antibody is a crucial tool in this context, enabling researchers to visualize vascular networks, evaluate structural changes, and study angiogenic activity in various biological samples.
Why CD31 Is a Key Marker for Blood Vessels
CD31 plays several roles in vascular biology, including cell-to-cell adhesion, leukocyte transmigration, and maintenance of endothelial integrity. Its high density on endothelial cell surfaces makes it ideal for labeling blood vessels, even when morphology alone is not enough to distinguish them. Additionally, CD31 is present in both large and small vessels, allowing comprehensive visualization of vascular architecture.
Unlike some markers that only label proliferating endothelial cells, CD31 marks both mature and developing vessels. This makes it applicable in a wide range of studies, from embryo development to tumor angiogenesis.
How Anti-CD31 Antibody Detects Blood Vessel Formation
1. Binding to Endothelial Cells
The primary function of an anti-CD31 antibody is to specifically bind to CD31 molecules on endothelial cells. This binding is highly selective, which allows researchers to clearly distinguish vascular tissue from surrounding structures. When the antibody is conjugated with a detection system such as fluorescent dyes, enzymes, or chromogenic labels—the bound endothelial cells become visible under a microscope.
This specific labeling makes it possible to:
- Map newly formed vessels
- Quantify vessel density
- Observe vascular remodeling
- Compare healthy vs. diseased tissue sections
2. Visualizing Angiogenesis in Tissue Sections
One of the most common applications is immunohistochemistry (IHC), where tissue sections are stained to reveal blood vessel patterns. Using this approach, researchers can assess how blood vessels grow, branch, or regress in different conditions. This is especially important in:
- Tumor angiogenesis studies
- Wound healing research
- Evaluation of anti-angiogenic therapies
- Analysis of ischemic tissue
Because CD31 is expressed uniformly across endothelial cells, the labeling reveals clear outlines of vessel walls, aiding in both qualitative and quantitative analysis.
3. Tracking Vascular Development in Experiments
The anti-CD31 antibody is also widely used in developmental biology and regenerative medicine. During embryogenesis, new blood vessels form rapidly, and identifying these structures helps researchers understand how organs mature and how tissues establish vascular supply. In stem cell research, CD31 staining helps confirm whether stem cell-derived endothelial cells successfully form vessel-like structures in vitro.
Quantifying Blood Vessel Density and Structure
Beyond simple visualization, scientists use CD31 staining to measure vascular parameters, such as:
- Microvessel density
- Vessel diameter
- Branching patterns
- Vessel complexity
- Endothelial proliferation
These metrics help evaluate angiogenesis in diseases like diabetic retinopathy, cancer, and cardiovascular disorders. In oncology, for instance, tumors with higher microvessel density often exhibit more aggressive behavior due to enhanced nutrient and oxygen supply.
Application in Tumor Angiogenesis Research
Because tumor growth relies heavily on the development of new blood vessels, studying angiogenesis is essential in cancer research. The anti-CD31 antibody helps identify even small and newly formed vessels within tumor tissue. By quantifying these vessels, scientists can assess how tumors respond to treatments designed to block angiogenesis, such as VEGF inhibitors or targeted therapies.
Advantages of Using Anti-CD31 Antibody
- High specificity: Strong and consistent labeling of endothelial cells.
- Versatility: Suitable for IHC, immunofluorescence, flow cytometry, and 3D models.
- Compatibility across species: Many versions detect CD31 in humans, mice, rats, and other animal models.
- Clear visualization: Provides well-defined vascular outlines.
These advantages make CD31 one of the most reliable and widely used vascular markers in biomedical research.
Conclusion
The anti-CD31 antibody is an indispensable tool for identifying blood vessel formation across a variety of biological contexts. Its ability to selectively label endothelial cells provides researchers with clear, detailed insights into vascular structure, density, and development.
Whether studying tumor angiogenesis, tissue repair, cardiovascular health, or embryonic development, CD31 staining remains one of the most effective and informative methods for visualizing and quantifying angiogenesis.